» Articles » PMID: 38603606

A Supervised Bayesian Factor Model for the Identification of Multi-omics Signatures

Overview
Journal Bioinformatics
Specialty Biology
Date 2024 Apr 11
PMID 38603606
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: Predictive biological signatures provide utility as biomarkers for disease diagnosis and prognosis, as well as prediction of responses to vaccination or therapy. These signatures are identified from high-throughput profiling assays through a combination of dimensionality reduction and machine learning techniques. The genes, proteins, metabolites, and other biological analytes that compose signatures also generate hypotheses on the underlying mechanisms driving biological responses, thus improving biological understanding. Dimensionality reduction is a critical step in signature discovery to address the large number of analytes in omics datasets, especially for multi-omics profiling studies with tens of thousands of measurements. Latent factor models, which can account for the structural heterogeneity across diverse assays, effectively integrate multi-omics data and reduce dimensionality to a small number of factors that capture correlations and associations among measurements. These factors provide biologically interpretable features for predictive modeling. However, multi-omics integration and predictive modeling are generally performed independently in sequential steps, leading to suboptimal factor construction. Combining these steps can yield better multi-omics signatures that are more predictive while still being biologically meaningful.

Results: We developed a supervised variational Bayesian factor model that extracts multi-omics signatures from high-throughput profiling datasets that can span multiple data types. Signature-based multiPle-omics intEgration via lAtent factoRs (SPEAR) adaptively determines factor rank, emphasis on factor structure, data relevance and feature sparsity. The method improves the reconstruction of underlying factors in synthetic examples and prediction accuracy of coronavirus disease 2019 severity and breast cancer tumor subtypes.

Availability And Implementation: SPEAR is a publicly available R-package hosted at https://bitbucket.org/kleinstein/SPEAR.

Citing Articles

Identification of a multi-omics factor predictive of long COVID in the IMPACC study.

Gabernet G, Maciuch J, Gygi J, Moore J, Hoch A, Syphurs C bioRxiv. 2025; .

PMID: 39990442 PMC: 11844572. DOI: 10.1101/2025.02.12.637926.


Predictive overfitting in immunological applications: Pitfalls and solutions.

Gygi J, Kleinstein S, Guan L Hum Vaccin Immunother. 2023; 19(2):2251830.

PMID: 37697867 PMC: 10498807. DOI: 10.1080/21645515.2023.2251830.

References
1.
Messias M, Mecatti G, Priolli D, de Oliveira Carvalho P . Plasmalogen lipids: functional mechanism and their involvement in gastrointestinal cancer. Lipids Health Dis. 2018; 17(1):41. PMC: 5842581. DOI: 10.1186/s12944-018-0685-9. View

2.
Klinge C . miRNAs and estrogen action. Trends Endocrinol Metab. 2012; 23(5):223-33. PMC: 3348384. DOI: 10.1016/j.tem.2012.03.002. View

3.
. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70. PMC: 3465532. DOI: 10.1038/nature11412. View

4.
Fourati S, Tomalin L, Mule M, Chawla D, Gerritsen B, Rychkov D . Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination. Nat Immunol. 2022; 23(12):1777-1787. PMC: 9747610. DOI: 10.1038/s41590-022-01329-5. View

5.
Argelaguet R, Arnol D, Bredikhin D, Deloro Y, Velten B, Marioni J . MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 2020; 21(1):111. PMC: 7212577. DOI: 10.1186/s13059-020-02015-1. View